Further studies are warranted to investigate asthma treatment effectiveness in childhood-onset asthma patients with obesity, early lifestyle weight-loss intervention strategies, and molecular therapeutic targets, such as adiponectin and the IL-6 trans-signaling pathway. This evidence concerns the gene ADIPOQ and obesity disorder.